B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Rabusertib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Rabusertib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

azd
2 shared targets
prexasertib
2 shared targets
sra
2 shared targets
azd
2 shared targets
nilotinib
2 shared targets
neratinib
2 shared targets
pelitinib
2 shared targets
pf
2 shared targets
r
2 shared targets
nintedanib
2 shared targets
Loading evidence profile...

This evidence profile for Rabusertib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.